Novel Multilayer Polymeric Inserts of Doxycycline for Treatment of Periodontal Diseases


Authors : Burhan Ali; Merajul Islam; Muktadir Hussain; Muhammad Hussain; Dr. Sumit Das

Volume/Issue : Volume 10 - 2025, Issue 5 - May


Google Scholar : https://tinyurl.com/4797trrm

DOI : https://doi.org/10.38124/ijisrt/25may1436

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.


Abstract : Objective: The objectives of this research was to formulate and evaluate novel multilayer chitosan inserts containing doxycycline hyclate for long term usage in periodontal diseases locally.  Methods: This research was carried out to formulate three different polymer based ( polymer used was chitostan) inserts that were uni, bi- and triple-layer inserts, and doxycycline hyclate as anti-microbial agents by means of solvent-casting method. The different layers of doxycycline loaded chitosan based inserts were tesed byFT- IR and DSC to evaluate the compatibilities of doxycycline hyclate and the chitosan and other additive present in this prepation. After compatibility study the physical parameters were examined. The physical properties included were difference in weight, thickness, durability, weight uniformity, % moisture absorbance, % moisture loss, swelling index, tensile strength, drug content uniformity, release pattern in-vitro antibacterial studies and stability and many more.  Results and Discussion: The evaluated data of various physicochemical properties indicates that all the inserts had same amount of drug as per content uniformity test and exhibited more than 150 times endurance capability. The percentage moisture loss varied between 24.155 ± 7.35 and 40.43 ± 11.737. Tensile strength was found to be more in case of bi and triple layer of inserts as compared to single layer, it varied in the range 1.55 0.0545to 4.543 ± 0.201 kg/mm2 . The drug pattern showed that the triple layer periodontal inserts exhibited controlled release drug pattern as compared to uni, bi layer inserts. The uni layer inserts exhibited the fasted release drug delivery pattern. The tripled layered drug loaded inserts continued their drug release for upto 17 days. The stability studies showed no signs of degradation, the degradation of the inserts were much less than the plain drug.  Conclusion: The study indicates that physicochemical parameters shown by all the inserts were found satisfactory. Thus, the inserts prepared as tri-layer could showed better performences and keep an efficient amount of drug for the treatment of Periodontitis.

Keywords : Chitosan, Inserts, Multilayer, Doxycycline Hyclate, Release Rate Antibacterial Activity.

References :

  1. Steinberg, Michael Friedman. Sustained release drug delivery for local treatment of dental diseases. Drug delivery devices, Fundamentals and applications. Editor: Tyles P. Marcel Dekker Inc, New York: Vol. 32, 1988; p. 492-515.
  2. Goodson JM, Holborow D, Dunn RL, Hogan P, Dunham S. Monolithic tetracycline containing fibers for controlled delivery to periodontal pockets. J Periodontal 1983; 54(11):575-79.
  3. Rahman S, Ahuja A, Ali J, Khar RK. Site specific delivery systems for treatment of periodontitis – Review article. Indian J. Pharm. Sci 2003; 65(2):106-12.
  4. Denis FK. Causation and pathogenesis of periodontal disease. Periodontology 2000-2001; 25:8-20.
  5. Albandar JM, Brunelle JA, Kingman A. Destrucive periodontal diseases in adults 30 years of age and older in United States, 1988-1994. J Periodontol 1999; 70:13-29.
  6. Brown LJ, Loe H. Prevalence. Extent, severity and progression of periodontal disease. Periodontology 2000. 1993; 2:57-71.
  7. Breck M, Gautchi M, Gehr P, Lang N. Variability of histological criteria in clinically healthy gingiva. J Periodontal Res 1987; 22:468-72.
  8. Lindhe J, Liljenberg B, Listgarten M. Some microbiological features of periodontal disease in man. J Periodontal 1980; 51:264-69.
  9. Muller GW, Schroeder H. The pocket epithelium: a light and electronic microscopic study. J Periodontal 1982; 53:133-44.
  10. Kinane DF, Lindhe J. Pathogenesis of periodontal disease. Text book of periodontology , Copenhagen: muksgaard,1997.
  11. Roskos KV, Fritzinger BK, Armitage GC, Heller. Development of a drug delivery system for the treatment of periodontal disease based on bioerodible poly (orthoesters). Biomaterials 1995; 16:313-317.
  12. Magnusson I, Lindhe J, Yoneyamma T, Lilzenberg B. Recolonization of subgingival microbials following scaling in deep pockets. J Clin Periodontal 1984; 11:193-207.   
  13. David LJ, Sebastian C. Antimicrobial and other chemotherapeutic agents in periodontal therapy. Chapter 14 in Fermin A. Carranza and Michael G. Newman. Clinical Periodontology. Prism books Pvt. Ltd., New Delhi; 1996; 511-13.
  14. Muller HP, Eickholz P. Heineke A, Pohl S, Muller RF, Lange DE. Simultaneous isolation of Actinobacillus actinomycetecomitans from subgingival and extracervicular locations of themouth. J Clin..Periodontol 1995; 22: 413-419.
  15. Muller HP, Lange DE, Muller RF. Failure of adjunctive minocycline HCl to eliminate oral Actinobacillus actinomycetemcomitans. J Clin Periodontol 1993; 20: 498-504.
  16. Sunil Agarwal, Venkatesh M, Udupa N. Controlled drug delivery systems for periodontitis. The pharma review 2004, Jul-Aug; 2 (11): 61-82. 
  17. Yamagami H, Takamori A, Sakamoto T, Okuda M. J Periodontal 1992;
    (63): 2-6.
  18. Freidman M, Steinberg D. Sustained release delivery systems for treatment of dental diseases. Pharm. Res. 1990; 7: 313-317.
  19. Larsen T. Invitro release of doxycycline from bioabsorbable materials and acrylic strips. J Periodontal 1990; 61: 30-34.
  20. Korman KS. Controlled release local delivery antimicrobial in periodontitis: Prospects of the future. J Periodontal 1993; 64: 782-91.
  21. Venkateshwari Y, Jayachandra RB, Sampath Kumar D, Mittal N, Pandit JK. Development of low cost tetracycline strip for long term treatment of periodontal. 23
  22. Ramesh D, Vijaya, Sehgal DK.Biological activity and theraputic applications of collagen. Indian drugs 2000;37(3). 
  23. Robinson JR, Vincent HL,Lee.Controlled drur delivery, fundamental and applications. 2nd ed:Marcel dekker, 1987;159-163.
  24. Tonet MS. Local delivery of tetracycline: from concept of clinical applications. J. Clin Periodontal 1998; 25:969-977.
  25. Kornman Ks. Controlled release local delivery of antimicrobials in periodontitis, propects of the future .J. Periodontal, 1993; 64:782-791.
  26. Doxycycline hyclate: draft proposal for revision of published monograph in the international pharmacopoeia: october 2006.
  27. www.drugbank.com.
  28. www.wekipedia.com
  29. Chawla Viney, Dureja Harison. Chitosan-preparation and properties, Indian drugs 2001; 39 (4): 191-194.
  30. Book of Pharmaceutical Excepients by Raymond C Rowe, Paul J Sheskey and Sian C Owen: pg no.2215
  31. Ikinci G, Senel S, Akmcibay H, Kas, Erci S, Wilson S, Wilson CG, Hmcal AA. Effect of chitosan on a periodontal pathogen porphyromonas gingivalis. J periodontol 2002 Jan: 545-558.
  32. Perugini P, Genta I, Conti B, Modena T, Paranetto F. Periodontal delivery of ipriflavone: new chitosan / PLGA film delivery system for a lipophilic drug. J Periodontol 2002.
  33. Yadav AV, Bhise SB. Chitin And Chitosan: Versatile polysaccharides of clinical importance. Indian J Pharm. Edu. 2005 Jan-Mar; 39(1): 27-34.
  34. Gaurav Tiwari. Release Studies of Metronidazole and doxycycline from Polycaprolactone films prepared by solvent evaporation. International Journal of ChemTech Research. 2010; 2(3):1384-1386.
  35. Mohammed M Al-Abdaly,   Abdel-Nassev Mel-Refai, Usaina M Gouda and Hossam Abdel Atty. Local Delivery of Atridox (Doxycycline gel) as Adjunctive in Management of Chronic Periodontitis. Suez Canal Univ Med J. 2008 March; 11(1): 41-46.
  36. Thawatchai Phaechamud and Juree Charoenteeraboon. Antibacterial activity and drug release of chitosan sponge containing doxycycline hyclate. AAPS PharmSciTech. 2008; 9(3): 829-835.
  37. N.Damodharan, V.Manimaran, B.Sravanthi. Formulation development and evaluation of delayed release doxycycline tablets. International journal of pharmacy and pharmaceutical sciences.2010; 2(1):116-119.
  38. 99(4).
  39. S.Shanmuganathan, N. Shanumugasundaram, N. Adhirajan, T.S. Ramyaa Lakshmi, MaryBabu. Preparation and characterization of chitosan microsphere for doxycycline delivery. European journal of pharmaceutics and biopharmaceutics 2008 July; 73(2): 201–211.
  40. MarcoAntonio Botelho.Nanotechnology in ligature-induced periodontitis: protective effect of a doxycycline gel with nanoparticules.
  41. Narayana Charyulu et al., developed strips of chitosan polymer 2% containing ciprofloxacin Hcl, norfloxacin and doxycycline by solution casting method using 1% acetic acid as casting solvent.   
  42. Heba A. Gad, Mohamed A. El-Nabarawi, and Seham S. Abd El-Hady. Formulation and evaluation of PLA and PLGA insitu implants containing secnidazole and/or doxycycline for treatment of periodontitis. AAPS Pharm Sci Tech. 2008 September; 9(3).
  43. Shankraiah.M, Nagesh.C, Venkatesh.J.S, Lakshminarsu.M, S.Ramachandra Setty. Local drug delivery system of chitosan strips containing sparfloxacin for periodontal disease. Pharmacology online 1.2011: 237-247.
  44. Dan Mei, Shirui Mao, Wei Sun, Yanjun Wang, Thomas Kissel. Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats. European journal of pharmaceutics and biopharmaceutics. 2008; 70: 874–881.
  45. Barat Romi, Srinatha Anegundha et al., Chitosan inserts for periodontitis: influence the drug loading plasticizer and cross linking on invitro metron idazole release. Acta pharma. 2007; 57: 469-477.  
  46. Senel S.G.Ikinic et al., Chitosan films and hydrogel of chlorhexidine gluconate for oral mucosal delivery. International journal of pharmaceutics. 2000; 193: 197-203. 
  47. Amal Hassan El-Kamel, Lubna Y. Ashri, and Ibrahim A. Alsarra. Micromatricial metronidazole benzoate film as a local mucoadhesive delivery system for treatment of periodontal diseases. AAPS PharmSciTech 2007; 8 (3).
  48. Ritu B. Dixit, Rahul A. Uplana, Vishnu A. Patel, Bharat C. Dixit, Tarosh S. Patel. Development and evaluation of cefadroxil drug loaded biopolymeric films based on chitosan-furfural schiff base.Scientia pharmaceutica. 2010; 78: 909–925.
  49. Mohammed Gulzar Ahmed, Narayana Charyulu.R, Kanthraj.K, Harish.N.M and Prabhakar Prabhu. Preparation and evaluation of periodontal strips of gatifloxacin periodontal diseases. International Journal of Pharma and Bio Sciences. Jul-Sep; 1(3).
  50. S.Sangeetha1, Harish.G And Malay.K.Samanta. Chitosan-based nanospheres as drug delivery system for Cytarabine. International journal of pharma and bio sciences. 2010; 1(2).
  51. K. Bansal, M. K. Rawat, A. Jain, A. Rajput, T. P. Chaturvedi And S. Singh. Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS PharmSciTech. 2009 September; 10(3).
  52. Mohammed Gulzar Ahmed, Narayana Charyulu.R, Harish.N.M and Prabhakar Prabhu.Formulation and in-vitro evaluation of chitosan films containg tetracyclines for the treatment of periodontitis. Asian journal of pharmaceutics. 2009; April-June. 
  53. M.Shankaraiah, C. Nagesh, J.S. Venkatesh, M.Lakshimi Narsu. International research journal pharmacy.2011; 2(4): 217-221.
  54. G.L.Prabhushankar, B.Gopalkrishna, Manjunatha K.M and Girisha C.H. Formulation and evaluation of levofloxacin dental films for Periodontitis. International   journal of pharmacy and pharmaceutical sciences. 2010; 2(1).
  55. Mastiholimath V.S., Dandagi P.M., et al., Formulation and evaluation of  levofloxacin dental films for periodontitis disease. International journal of pharmacy and pharmaceutical sciences. 2010; 2(1): 162-166.
  56. Hong Hua, Chi Ping, Liu Changsheng. Fabrication and properties of multilayer
  57. chitosan membrane loaded with tinidazole. Journal of wuhan university of technology-mater. Sci. Ed. 2007 Feb; 22(1).
  58. Sujatha Muchalambe, Dandagi Pm, Yogesh Hs, Ravindra R, Gopalakrishna B.  International journal of pharmaceutical sceiences. 2010 May-Aug; 2(2): 601-611.
  59. K.Schwach-Abdellaouia,, N.Vivien-Castionib, R. Gurnya. European journal of pharmaceutics and biopharmaceutics. 2000; 50: 83-99.
  60. Vineet Bhardwaj  Vikesh Shukla, Narendra Goyal, Rishabha Malviya. Formulation  and evaluation of different concentration chitosan  based Periodental film of Ofloxacin. Journal of Pharmacy Research. 2010; 3(3): 528-532.
  61. Steinberg D, Freidman M, Sakamoto T, Okado H. Intra pocket chemotherapy in adult periodontitis using a new controlled release insert containg ofloxacin.
  62. J Periodontal. 1992; 63: 2-6.
  63. Hitzig C, Charbit Y, Bitton C, Foss T, Tebaul M, Hannoum L, Varonne R. Topical metronidazole as an adjunct to subgingival debridement in the treatment of chronic periodontitis. J Clin Periodontal. 1994; 21: 141-151.    
  64. Kurien Rajesh. Effect of ciprofloxacin and norfloxacin controlled release inserts on periodontal flora. A clinical and microbiological study. Dissertation submitted to Mangalore University. 1994.
  65. Pharmacopoeia of india, Vol II, 3rd edition, A-143.
  66. Silverstein M, Webster X.Spectrometric identification of organic compounds.6th ed.  New York: John Wiley and Sons; 1998.
  67. Sharma YR. Elementary organic spectroscopy. New Delhi: S.Chand and Company Ltd; 2003.

Objective: The objectives of this research was to formulate and evaluate novel multilayer chitosan inserts containing doxycycline hyclate for long term usage in periodontal diseases locally.  Methods: This research was carried out to formulate three different polymer based ( polymer used was chitostan) inserts that were uni, bi- and triple-layer inserts, and doxycycline hyclate as anti-microbial agents by means of solvent-casting method. The different layers of doxycycline loaded chitosan based inserts were tesed byFT- IR and DSC to evaluate the compatibilities of doxycycline hyclate and the chitosan and other additive present in this prepation. After compatibility study the physical parameters were examined. The physical properties included were difference in weight, thickness, durability, weight uniformity, % moisture absorbance, % moisture loss, swelling index, tensile strength, drug content uniformity, release pattern in-vitro antibacterial studies and stability and many more.  Results and Discussion: The evaluated data of various physicochemical properties indicates that all the inserts had same amount of drug as per content uniformity test and exhibited more than 150 times endurance capability. The percentage moisture loss varied between 24.155 ± 7.35 and 40.43 ± 11.737. Tensile strength was found to be more in case of bi and triple layer of inserts as compared to single layer, it varied in the range 1.55 0.0545to 4.543 ± 0.201 kg/mm2 . The drug pattern showed that the triple layer periodontal inserts exhibited controlled release drug pattern as compared to uni, bi layer inserts. The uni layer inserts exhibited the fasted release drug delivery pattern. The tripled layered drug loaded inserts continued their drug release for upto 17 days. The stability studies showed no signs of degradation, the degradation of the inserts were much less than the plain drug.  Conclusion: The study indicates that physicochemical parameters shown by all the inserts were found satisfactory. Thus, the inserts prepared as tri-layer could showed better performences and keep an efficient amount of drug for the treatment of Periodontitis.

Keywords : Chitosan, Inserts, Multilayer, Doxycycline Hyclate, Release Rate Antibacterial Activity.

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe